LP23 is a non-aryl methylamine PD-1/PD-L1 inhibitor (IC50: 16.7 nM) with antitumor activity; it restores immune cell function in HepG2/Jurkat T cells, promotes HepG2 cell death, and exhibits in vivo efficacy in the B16-F10 tumor model (TGI = 88.6% at 30 mg/kg).